Developer Platform

REGENXBIO - REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

Humacyte - Humacyte develops products for vascular diseases and replacement of anatomical conduits.

Neuralink - Neuralink develops a brain machine interface that provides solutions for those with paralysis.

Xencor - Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Aurinia Pharmaceuticals - Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Praxis Precision Medicines - Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

OptiNose - OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

Ardelyx - Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.

Metsera - Metsera develops oral and injectable therapies for obesity and metabolic diseases.

Adaptimmune - Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.

© 2025 bioDAO.ai